156 related articles for article (PubMed ID: 9715149)
1. Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium Tc 99m 88BV59H21-2V67-66 (HumaSPECT-Tc), a totally human monoclonal antibody. Patient management benefit from a phase III multicenter study.
Wolff BG; Bolton J; Baum R; Chetanneau A; Pecking A; Serafini AN; Fischman AJ; Hoover HC; Klein JL; Wynant GE; Subramanian R; Goroff DK; Hanna MG
Dis Colon Rectum; 1998 Aug; 41(8):953-62. PubMed ID: 9715149
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunoscintigraphy of recurrent, metastatic, or occult colorectal cancer with technetium 99m-labeled totally human monoclonal antibody 88BV59: results of pivotal, phase III multicenter studies.
Serafini AN; Klein JL; Wolff BG; Baum R; Chetanneau A; Pecking A; Fischman AJ; Hoover HC; Wynant GE; Subramanian R; Goroff DK; Hanna MG
J Clin Oncol; 1998 May; 16(5):1777-87. PubMed ID: 9586891
[TBL] [Abstract][Full Text] [Related]
3. Technetium 99m-labeled IMMU-4, a monoclonal antibody against carcinoembryonic antigen, for imaging of occult recurrent colorectal cancer in patients with rising serum carcinoembryonic antigen levels.
Patt YZ; Podoloff DA; Curley S; Kasi L; Smith R; Bhadkamkar V; Charnsangavej C
J Clin Oncol; 1994 Mar; 12(3):489-95. PubMed ID: 8120546
[TBL] [Abstract][Full Text] [Related]
4. Use of carcinoembryonic antigen radioimmunodetection and computed tomography for predicting the resectability of recurrent colorectal cancer.
Hughes K; Pinsky CM; Petrelli NJ; Moffat FL; Patt YZ; Hammershaimb L; Goldenberg DM
Ann Surg; 1997 Nov; 226(5):621-31. PubMed ID: 9389396
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunoscintigraphy of colorectal carcinoma using technetium-99m-labeled, totally human monoclonal antibody 88BV59H21-2.
Gulec SA; Serafini AN; Moffat FL; Vargas-Cuba RD; Sfakianakis GN; Franceschi D; Crichton VZ; Subramanian R; Klein JL; De Jager RL
Cancer Res; 1995 Dec; 55(23 Suppl):5774s-5776s. PubMed ID: 7493345
[TBL] [Abstract][Full Text] [Related]
6. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
[TBL] [Abstract][Full Text] [Related]
7. Preoperative scintigraphy and operative probe scintimetry of colorectal carcinoma using technetium-99m-88BV59.
Moffat FL; Vargas-Cuba RD; Serafini AN; Jabir AM; Sfakianakis GN; Sittler SY; Robinson DS; Crichton VZ; Subramanian R; Murray JH
J Nucl Med; 1995 May; 36(5):738-45. PubMed ID: 7738642
[TBL] [Abstract][Full Text] [Related]
8. Value of radioimmunoscintigraphy with technetium-99m labelled anti-CEA monoclonal antibody (BW431/26) in the detection of colorectal cancer.
Poshyachinda M; Chaiwatanarat T; Saesow N; Thitathan S; Voravud N
Eur J Nucl Med; 1996 Jun; 23(6):624-30. PubMed ID: 8662095
[TBL] [Abstract][Full Text] [Related]
9. Human monoclonal antibody 99mTc-88BV59: detection of colorectal cancer, recurrent or metastatic disease and immunogenicity assessment.
Krause BJ; Baum RP; Staib-Sebler E; Lorenz M; Niesen A; Hör G
Eur J Nucl Med; 1997 Jan; 24(1):72-5. PubMed ID: 9044881
[TBL] [Abstract][Full Text] [Related]
10. Radioimmunodetection of colorectal carcinoma using technetium-99m-labeled Fab' fragments of the IMMU-4 anti-carcinoembryonic antigen monoclonal antibody.
Moffat FL; Vargas-Cuba RD; Serafini AN; Casillas VJ; Morillo G; Benedetto P; Robinson DS; Ardalan B; Manten HD; Clark KC
Cancer; 1994 Feb; 73(3 Suppl):836-45. PubMed ID: 8306268
[TBL] [Abstract][Full Text] [Related]
11. 99Tcm-IMMU4 imaging in recurrent colorectal cancer: efficacy and impact on surgical management.
Sirisriro R; Podoloff DA; Patt YZ; Curley SA; Kasi LP; Bhadkamkar VA; Kim EE; Murray JL; Smith R; Haynie TP
Nucl Med Commun; 1996 Jul; 17(7):568-76. PubMed ID: 8843115
[TBL] [Abstract][Full Text] [Related]
12. Current status of cancer immunodetection with radiolabeled human monoclonal antibodies.
De Jager R; Abdel-Nabi H; Serafini A; Pecking A; Klein JL; Hanna MG
Semin Nucl Med; 1993 Apr; 23(2):165-79. PubMed ID: 8511602
[TBL] [Abstract][Full Text] [Related]
13. Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases.
Patt YZ; Lamki LM; Shanken J; Jessup JM; Charnsangavej C; Ajani JA; Levin B; Merchant B; Halverson C; Murray JL
J Clin Oncol; 1990 Jul; 8(7):1246-54. PubMed ID: 2193120
[TBL] [Abstract][Full Text] [Related]
14. Detection efficiency of colorectal carcinoma recurrence using technetium pertechnetate-anti-carcinoembryonic antigen monoclonal antibody BW 431/26.
Zwas ST; Goshen E; Rath P; Brenner H; Klein E; Ben-Ari G
Cancer; 1995 Jul; 76(2):215-22. PubMed ID: 8625094
[TBL] [Abstract][Full Text] [Related]
15. Imaging of colorectal carcinoma with technetium-99m radiolabeled Fab' fragments.
Podoloff DA; Patt YZ; Curley SA; Kim EE; Bhadkamkar VA; Smith RE
Semin Nucl Med; 1993 Apr; 23(2):89-98. PubMed ID: 8511605
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody imaging in patients with colorectal cancer and increasing levels of serum carcinoembryonic antigen. Experience with ZCE-025 and IMMU-4 monoclonal antibodies and proposed directions for clinical trials.
Patt YZ; Podoloff DA; Curley S; Smith R; Badkhamkar VA; Lamki LM; Jessup MM; Hohn DC
Cancer; 1993 Jun; 71(12 Suppl):4293-7. PubMed ID: 8389662
[TBL] [Abstract][Full Text] [Related]
17. Detection of pelvic recurrence of colorectal carcinoma: prospective, blinded comparison of Tc-99m-IMMU-4 monoclonal antibody scanning and CT.
Stomper PC; D'Souza DJ; Bakshi SP; Rodriguez-Bigas M; Burke PA; Petrelli NJ
Radiology; 1995 Dec; 197(3):688-92. PubMed ID: 7480740
[TBL] [Abstract][Full Text] [Related]
18. Results of immunoscintigraphy using a cocktail of radiolabeled monoclonal antibodies in the detection of colorectal cancer.
Volpe CM; Abdel-Nabi HH; Kulaylat MN; Doerr RJ
Ann Surg Oncol; 1998 Sep; 5(6):489-94. PubMed ID: 9754756
[TBL] [Abstract][Full Text] [Related]
19. Radioimmunoscintigraphy of colorectal cancer with technetium-99m-labeled murine anti-carcinoembryonic antigen monoclonal antibody in athymic nude mice.
Watanabe N; Oriuchi N; Sugiyama S; Kuroki M; Matsuoka Y
Ann Nucl Med; 1994 Feb; 8(1):23-30. PubMed ID: 8204394
[TBL] [Abstract][Full Text] [Related]
20. 99mTc-IMMU-4 monoclonal antibody scan in colorectal cancer. A prospective study.
Rodriguez-Bigas MA; Bakshi S; Stomper P; Blumenson LE; Petrelli NJ
Arch Surg; 1992 Nov; 127(11):1321-4. PubMed ID: 1444794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
